Abstract
Antibiotics have saved several millions of lives, but its persistent use of antibiotics in the treatment of various infections, whether bacterial, fungal, viral or parasitic has lead to the development of antibiotic resistance. The rapid emergence of antibiotic resistant strains poses a serious challenge to existing antimicrobial therapies. Due to the increase in drug-resistant pathogens and failure of antibiotics the urgent need for the discovery of novel antimicrobials has been continuously emphasized in the global forum. Here we review about antimicrobial peptides (AMPs), their structural insights and recent developments. We had summarized the major classes, mechanism of action and biophysical parameters that modulate therapeutic potency of AMPs. Also, we had briefed the challenges involved in developing therapeutic peptides and the global market potential for peptide therapeutics.
Similar content being viewed by others
References
Aboye TL, Strömstedt AA, Gunasekera S, Bruhn JG, El-Seedi H, Rosengren KJ, Göransson U (2015) A cactus-derived toxin-like cystine knot peptide with selective antimicrobial activity. Chembiochem 16(7):1068–1077
Afacan JN, Yeung TYA, Pena MO, Hancock EWR (2012) Therapeutic potential of host defense peptides in antibiotic-resistant infections. Curr Pharm Des 18(6):807–819
AlKhatib Z, Lagedroste M, Fey I, Kleinschrodt D, Abts A, Smits SH (2014) Lantibiotic immunity: inhibition of nisin mediated pore formation by NisI. PLoS ONE 9(7):e102246
Antibiotic/Antimicrobial Resistance (2017) Centers for Disease Control and Prevention. https://www.cdc.gov/drugresistance/biggest_threats.html. Accessed 09 Oct 2017
Aoki W, Ueda M (2013) Characterization of antimicrobial peptides toward the development of novel antibiotics. Pharmaceuticals 6(8):1055–1081
Arenas I, Villegas E, Walls O, Barrios H, Rodríguez R, Corzo G (2016) Antimicrobial activity and stability of short and long based arachnid synthetic peptides in the presence of commercial antibiotics. Molecules 21(2):225
Bahar AA, Ren D (2013a) Antimicrobial peptides. Pharmaceuticals 6(12):1543–1575
Bahar AA, Ren D (2013b) Antimicrobial peptides. Pharmaceuticals 6(12):1543–1575
Bechinger B, Gorr SU (2016) Antimicrobial peptides mechanisms of action and resistance. J Dent Res 96:254
Boman HG, Agerberth B, Boman A (1993) Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 61(7):2978–2984
Bommarius B, Jenssen H, Elliott M, Kindrachuk J, Pasupuleti M, Gieren H et al (2010) Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides 31(11):1957–1965
Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3(3):238–250
Cao H, Ke T, Liu R, Yu J, Dong C, Cheng M, Liu S (2015) Identification of a novel proline-rich antimicrobial peptide from Brassica napus. PLoS ONE 10(9):e0137414
Choi H, Rangarajan N, Weisshaar JC (2016) Lights, camera, action! Antimicrobial peptide mechanisms imaged in space and time. Trends Microbiol 24(2):111–122
Čujová S, Bednárová L, Slaninová J, Straka J, Čeřovský V (2014) Interaction of a novel antimicrobial peptide isolated from the venom of solitary bee Colletes daviesanus with phospholipid vesicles and Escherichia coli cells. J Pept Sci 20(11):885–895
Dalzini A, Bergamini C, Biondi B, De Zotti M, Panighel G, Fato R, Maniero AL (2016) The rational search for selective anticancer derivatives of the peptide trichogin GA IV: a multi-technique biophysical approach. Sci Rep 6:2400
de Oliveira Dias R, Franco OL (2015) Cysteine-stabilized αβ defensins: from a common fold to antibacterial activity. Peptides 72:64–72
Deslouches B, Phadke SM, Lazarevic V, Cascio M, Islam K, Montelaro RC, Mietzner TA (2005) De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob Agents Chemother 49(1):316–322
Destoumieux D, Bulet P, Loew D, Van Dorsselaer A, Rodriguez J, Bachère E (1997) Penaeidins, a new family of antimicrobial peptides isolated from the shrimp Penaeus vannamei (Decapoda). J Biol Chem 272(45):28398–28406
Duong DT, Singh S, Bagheri M, Verma NK, Schmidtchen A, Malmsten M (2016) Pronounced peptide selectivity for melanoma through tryptophan end-tagging. Sci Rep 6:24952
Dziuba B, Dziuba M (2014) New milk protein-derived peptides with potential antimicrobial activity: an approach based on bioinformatic studies. Int J Mol Sci 15(8):14531–14545
Ebbensgaard A, Mordhorst H, Overgaard MT, Nielsen CG, Aarestrup FM, Hansen EB (2015) Comparative evaluation of the antimicrobial activity of different antimicrobial peptides against a range of pathogenic bacteria. PLoS ONE 10(12):e0144611
Ebenhan T, Gheysens O, Kruger HG, Zeevaart JR, Sathekge MM (2014) Antimicrobial peptides: their role as infection-selective tracers for molecular imaging. BioMed Res Int 2014:867381
Edwards IA, Elliott AG, Kavanagh AM, Zuegg J, Blaskovich MA, Cooper MA (2016) Contribution of amphipathicity and hydrophobicity to the antimicrobial activity and cytotoxicity of β-hairpin peptides. ACS Infect Dis 2(6):442
Elliott KA, Kenny C, Madan J (2017) A global treaty to reduce antimicrobial use in livestock. https://www.cgdev.org/sites/default/files/global-treaty-reduce-antimicrobial-use-livestock.pdf. Accessed 10 Oct 2017
Elofsson U, Fureby A, Gerde P (2015) Pulmonary delivery of antimicrobial peptides. ONdrugDelivery 57:4–7
Farkas A, Maróti G, Kereszt A, Kondorosi É (2017) Comparative analysis of the bacterial membrane disruption effect of two natural plant antimicrobial peptides. Front Microbiol 8:51
Fosgerau K, Hoffmann T (2015) Peptide therapeutics: current status and future directions. Drug Discov Today 20(1):122–128
Friedrich CL, Rozek A, Patrzykat A, Hancock RE (2001) Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria. J Biol Chem 276(26):24015–24022
Gentilucci L, De Marco R, Cerisoli L (2010) Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. Curr Pharm Des 16(28):3185–3203
Ghosh S (2016) Peptide therapeutics market: forecast and analysis 2015–2025. Chim OGGI-Chem Today 34(2):V–VII
Hamoen LW, Wenzel M (2017) Antimicrobial peptides-interaction with membrane lipids and proteins. Front Cell Dev Biol 5:4
Henderson JM, Waring AJ, Separovic F, Lee KYC (2016) Antimicrobial peptides share a common interaction driven by membrane line tension reduction. Biophys J 111(10):2176–2189
Hirst DJ, Lee TH, Kulkarni K, Wilce JA, Aguilar MI (2016) The impact of cell-penetrating peptides on membrane bilayer structure during binding and insertion. Biochim Biophys Acta 1858(8):1841–1849
Hoagland DT, Liu J, Lee RB, Lee RE (2016) New agents for the treatment of drug-resistant Mycobacterium tuberculosis. Adv Drug Deliv Rev 102:55–72
Hollmann A, Martínez M, Noguera ME, Augusto MT, Disalvo A, Santos NC et al (2016) Role of amphipathicity and hydrophobicity in the balance between hemolysis and peptide–membrane interactions of three related antimicrobial peptides. Colloids Surf B 141:528–536
Huang Y, He L, Li G, Zhai N, Jiang H, Chen Y (2014) Role of helicity of α-helical antimicrobial peptides to improve specificity. Protein Cell 5(8):631–642
Hutchings CJ, Koglin M, Olson WC, Marshall FH (2017) Opportunities for therapeutic antibodies directed at G-protein-coupled receptors. Nat Rev Drug Discov 16:1–24
Imjongjirak C, Amphaiphan P, Charoensapsri W, Amparyup P (2017) Characterization and antimicrobial evaluation of SpPR-AMP1, a proline-rich antimicrobial peptide from the mud crab Scylla paramamosain. Dev Comp Immunol 74:209–216
Ingham AB, Moore RJ (2007) Recombinant production of antimicrobial peptides in heterologous microbial systems. Biotechnol Appl Biochem 47(1):1–9
Izadpanah M, Khalili H (2015) Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: an evidence-based literature review. J Res Pharm Pract 4(3):105–114
Jenssen H, Aspmo SI (2008) Serum stability of peptides. Peptide-Based Drug Des 498:177–186
Jirku M, Bumba L, Bednarova L, Kubala M, Sulc M, Franek M, Bousova K (2015) Characterization of the part of N-terminal PIP2 binding site of the TRPM1 channel. Biophys Chem 207:135–142
Kitagawa M, Shiraishi T, Yamamoto S, Kutomi R, Ohkoshi Y, Sato T, Yokota SI (2017) Novel antimicrobial activities of a peptide derived from a Japanese soybean fermented food, Natto, against Streptococcus pneumoniae and Bacillus subtilis group strains. AMB Expr 7(1):127
Koh JJ, Lin H, Caroline V, Chew YS, Pang LM, Aung TT, Tan AL (2015) N-lipidated peptide dimers: effective antibacterial agents against gram-negative pathogens through lipopolysaccharide permeabilization. J Med Chem 58(16):6533–6548
Kovalainen M, Mönkäre J, Riikonen J, Pesonen U, Vlasova M, Salonen J, Herzig KH (2015) Novel delivery systems for improving the clinical use of peptides. Pharmacol Rev 67(3):541–561
Kumar S, Prakash S, Gupta K, Dongre A, Balaram P, Balaram H (2016) Unexpected functional implication of a stable succinimide in the structural stability of Methanocaldococcus jannaschii glutaminase. Nat Commun 7:12798
Le CF, Yusof MYM, Hassan H, Sekaran SD (2015) In vitro properties of designed antimicrobial peptides that exhibit potent antipneumococcal activity and produces synergism in combination with penicillin. Sci Rep 5:9761
Le CF, Gudimella R, Razali R, Manikam R, Sekaran SD (2016) Transcriptome analysis of Streptococcus pneumoniae treated with the designed antimicrobial peptides, DM3. Sci Rep 6:26828
Lee J, Lee DG (2015) Antimicrobial peptides (AMPs) with dual mechanisms: membrane disruption and apoptosis. J Microbiol Biotechnol 25(6):759–764
Lee TH, Hirst DJ, Aguilar MI (2015) New insights into the molecular mechanisms of biomembrane structural changes and interactions by optical biosensor technology. Biochim Biophys Acta 1848(9):1868–1885
Lee BS, Huang JS, Jayathilaka LP, Lee J, Gupta S (2016) Antibody production with synthetic peptides. Methods Mol Biol 1474:25–47
Leontiadou H, Mark AE, Marrink SJ (2006) Antimicrobial peptides in action. J Am Chem Soc 128(37):12156–12161
Li Y, Ducasse R, Zirah S, Blond A, Goulard C, Lescop E, Rebuffat S (2015) Characterization of sviceucin from Streptomyces provides insight into enzyme exchangeability and disulfide bond formation in lasso peptides. ACS Chem Biol 10(11):2641–2649
Li J, Koh JJ, Liu S, Lakshminarayanan R, Verma CS, Beuerman RW (2017) Membrane active antimicrobial peptides: translating mechanistic insights to design. Front Neurosci 11:73
Limoli DH, Rockel AB, Host KM, Jha A, Kopp BT, Hollis T, Wozniak DJ (2014) Cationic antimicrobial peptides promote microbial mutagenesis and pathoadaptation in chronic infections. PLoS Pathog 10(4):e1004083
Liu WP, Chen YH, Ming X, Kong Y (2015) Design and synthesis of a novel cationic peptide with potent and broad-spectrum antimicrobial activity. BioMed Res Int. https://doi.org/10.1155/2015/578764
Liu X, Cao R, Wang S, Jia J, Fei H (2016) Amphipathicity determines different cytotoxic mechanisms of lysine-or arginine-rich cationic hydrophobic peptides in cancer cells. J Med Chem 59(11):5238–5247
Liu CJ, Wu L, Meng E, Zhang DY (2017) The development of high-throughput identification and heterologous expression of valuable peptides/proteins. Curr Proteom 14(1):13–23
Lomakin IB, Gagnon MG, Steitz TA (2015) Antimicrobial peptides targeting bacterial ribosome. Oncotarget 6(22):18744
Long SW, Linson SE, Saavedra MO, Cantu C, Davis JJ, Brettin T, Olsen RJ (2017) Whole-Genome sequencing of human clinical Klebsiella pneumoniae isolates reveals misidentification and misunderstandings of Klebsiella pneumoniae, Klebsiella variicola, and Klebsiella quasipneumoniae. mSphere 2(4):e00290–e00217
Lyu Y, Yang Y, Lyu X, Dong N, Shan A (2016) Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida. Sci Rep 6:27285
Manabe T, Kawasaki K (2017) D-form KLKLLLLLKLK-NH2 peptide exerts higher antimicrobial properties than its L-form counterpart via an association with bacterial cell wall components. Sci Rep 7:43384
Mardirossian M, Grzela R, Giglione C, Meinnel T, Gennaro R, Mergaert P, Scocchi M (2014) The host antimicrobial peptide Bac7 1–35 binds to bacterial ribosomal proteins and inhibits protein synthesis. Chem Biol 21(12):1639–1647
Martin L, Van Meegern A, Doemming S, Schuerholz T (2015) Antimicrobial peptides in human sepsis. Front Immunol 6:404
Mathur D, Prakash S, Anand P, Kaur H, Agrawal P, Mehta A, Raghava GP (2016) PEPlife: a repository of the half-life of peptides. Sci Rep 6:36617
Miyasaki KT, Lehrer RI (1998) β-sheet antibiotic peptides as potential dental therapeutics. Int J Antimicrob Agents 9(4):269–280
Montero-Alejo V, Corzo G, Porro-Suardíaz J, Pardo-Ruiz Z, Perera E, Rodríguez-Viera L, Tytgat J (2017) Panusin represents a new family of β-defensin-like peptides in invertebrates Dev Comp Immunol 67:310–321
Muheem A, Shakeel F, Jahangir MA, Anwar M, Mallick N, Jain GK, Ahmad FJ (2016) A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives. Saudi Pharm J 24(4):413–428
Müller A, Wenzel M, Strahl H, Grein F, Saaki TN, Kohl B, Hamoen LW (2016) Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains. Proc Natl Acad Sci 113(45):E7077–E7086
Nam BH, Moon JY, Park EH, Kim YO, Kim DG, Kong HJ et al (2014) Antimicrobial activity of peptides derived from olive flounder lipopolysaccharide binding protein/bactericidal permeability-increasing protein (LBP/BPI). Mar Drugs 12(10):5240–5257
Narayana JL, Chen JY (2015) Antimicrobial peptides: possible anti-infective agents. Peptides 72:88–94
Nešuta O, Buděšínský M, Hadravová R, Monincová L, Humpoličková J, Čeřovský V (2017) How proteases from Enterococcus faecalis contribute to its resistance to short α-helical antimicrobial peptides. Pathog Dis 75(7):ftx091
New antimicrobial peptide kills strains resistant to existing antibiotics (2016) http://www.kurzweilai.net/new-antimicrobial-peptide-kills-strains-resistant-to-existing-antibiotics. Accessed on 10 October 2017
Ngambenjawong C, Gustafson HH, Pineda JM, Kacherovsky NA, Cieslewicz M, Pun SH (2016) Serum stability and affinity optimization of an M2 macrophage-targeting peptide (M2pep). Theranostics 6(9):1403
Nordström R, Malmsten M (2017) Delivery systems for antimicrobial peptides. Adv Colloid Interface Sci 242:17
Pasupuleti M (2009) Structural, functional and evolutionary studies of antimicrobial peptides, vol 2009, no 85. Department of Clinical Sciences, Lund University, Lund
Patel S, Akhtar N (2017) Antimicrobial peptides (AMPs): the quintessential ‘offense and defense’ molecules are more than antimicrobials. Biomed Pharmacother 95:1276–1283
Peng SY, You RI, Lai MJ, Lin NT, Chen LK, Chang KC (2017) Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2. Sci Rep 7:11477
Petit VW, Rolland JL, Blond A, Cazevieille C, Djediat C, Peduzzi J, Rebuffat S (2016) A hemocyanin-derived antimicrobial peptide from the penaeid shrimp adopts an alpha-helical structure that specifically permeabilizes fungal membranes. Biochim Biophys Acta 1860(3):557–568
Polanco C (2013) Selective antibacterial peptides: a review on their polarity: microbial pathogens and strategies for combating them: science, technology and education. Formatex Research Center, Badajoz
Premdjee B, Payne RJ (2017) Synthesis of proteins by native chemical ligation–desulfurization strategies. In: D’Andrea LD, Romanelli A (eds) Chemical ligation: tools for biomolecule synthesis and modification. Wiley, Hoboken
Pushpanathan M, Gunasekaran P, Rajendhran J (2013) Antimicrobial peptides: versatile biological properties. Int J Pept 15:42
Rashid R, Veleba M, Kline KA (2016) Focal targeting of the bacterial envelope by antimicrobial peptides. Front Cell Dev Biol 4:55
Riduan SN, Yuan Y, Zhou F, Leong J, Su H, Zhang Y (2016) Ultrafast killing and self-gelling antimicrobial imidazolium oligomers. Small 12(14):1928–1934
Sang P, Shi Y, Teng P, Cao A, Xu H, Li Q, Cai J (2017) Antimicrobial AApeptides. Curr Topics Med Chem 17(11):1266–1279
Sani MA, Lee TH, Aguilar MI, Separovic F (2015) Proline-15 creates an amphipathic wedge in maculatin 1.1 peptides that drives lipid membrane disruption. Biochim Biophys Acta 1848(10):2277–2289
Schmitt P, Rosa RD, Destoumieux-Garzón D (2016a) An intimate link between antimicrobial peptide sequence diversity and binding to essential components of bacterial membranes. Biochim Biophys Acta 1858(5):958–970
Schmitt P, Rosa RD, Destoumieux-Garzón D (2016b) An intimate link between antimicrobial peptide sequence diversity and binding to essential components of bacterial membranes. Biochim Biophys Acta 1858(5):958–970
Schneider T, Kruse T, Wimmer R, Wiedemann I, Sass V, Pag U, Neve S (2010) Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science 328(5982):1168–1172
Scocchi M, Mardirossian M, Runti G, Benincasa M (2016) Non-membrane permeabilizing modes of action of antimicrobial peptides on bacteria. Curr Topics Med Chem 16(1):76–88
Seo MD, Won HS, Kim JH, Mishig-Ochir T, Lee BJ (2012) Antimicrobial peptides for therapeutic applications: a review. Molecules 17(10):12276–12286
Shahmiri M, Enciso M, Mechler A (2015) Controls and constrains of the membrane disrupting action of Aurein 1.2. Sci Rep 5:16378
Sharma H, Nagaraj R (2015) Human β-Defensin 4 with non-native disulfide bridges exhibit antimicrobial activity. PLoS ONE 10(3):e0119525
Shen W, Chen Y, Yao H, Du C, Luan N, Yan X (2016) A novel defensin-like antimicrobial peptide from the skin secretions of the tree frog, Theloderma kwangsiensis. Gene 576(1):136–140
Silva ON, De La Fuente-núñez C, Haney EF, Fensterseifer ICM, Ribeiro SM, Porto WF et al (2016) An anti-infective synthetic peptide with dual antimicrobial and immunomodulatory activities. Sci Rep. https://doi.org/10.1038/srep35465
Sitaram N, Nagaraj R (1999) Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity. Biochim Biophys Acta 1462(1):29–54
Tantong S, Pringsulaka O, Weerawanich K, Meeprasert A, Rungrotmongkol T, Sarnthima R, Sirikantaramas S (2016) Two novel antimicrobial defensins from rice identified by gene coexpression network analyses. Peptides 84:7–16
Thota CK, Yadav N, Chauhan VS (2016) A novel highly stable and injectable hydrogel based on a conformationally restricted ultrashort peptide. Sci Rep 6:31167
Tian Y, Li J, Zhao H, Zeng X, Wang D, Liu Q, Li Z (2016) Stapling of unprotected helical peptides via photo-induced intramolecular thiol–yne hydrothiolation. Chem Sci 7(5):3325–3330
Triana-Vidal LE, Castro MS, Pires Júnior OR, Álvares ACM, de Freitas SM, Fontes W et al (2017) Dendropsophin 1, a novel antimicrobial peptide from the skin secretion of the endemic Colombian frog Dendropsophus columbianus. Nat Prod Res. https://doi.org/10.1080/14786419.2017.1346646
Tseng TS, Wang SH, Chang TW, Wei HM, Wang YJ, Tsai KC, Chen C (2016) Sarkosyl-induced helical structure of an antimicrobial peptide gw-q6 plays an essential role in the binding of surface receptor OprI in Pseudomonas aeruginosa. PLoS ONE 11(10):e0164597
Van Harten RM, Willems RJ, Martin NI, Hendrickx AP (2017) Multidrug-resistant enterococcal infections: new compounds, novel antimicrobial therapies? Trends Microbiol 25:467
Ventola CL (2015) The antibiotic resistance crisis: part 1: causes and threats. Pharm Ther 40(4):277–283
Verdon J, Coutos-Thevenot P, Rodier MH, Landon C, Depayras S, Noel C, Berjeaud JM (2016) Armadillidin H, a glycine-rich peptide from the terrestrial crustacean Armadillidium vulgare, displays an unexpected wide antimicrobial spectrum with membranolytic activity. Front Microbiol 7:1484
Wang G (2012) Post-translational modifications of natural antimicrobial peptides and strategies for peptide engineering. Curr Biotechnol 1(1):72–79
Wang G, Mishra B, Lau K, Lushnikova T, Golla R, Wang X (2015) Antimicrobial peptides in 2014. Pharmaceuticals 8(1):123–150
Weinstock MT, Francis JN, Redman JS, Kay MS (2012) Protease-resistant peptide design—empowering nature’s fragile warriors against HIV. Pept Sci 98(5):431–442
Widenbring R, Frenning G, Malmsten M (2014) Chain and pore-blocking effects on matrix degradation in protein-loaded microgels. Biomacromol 15(10):3671–3678
Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55(1):27–55
Yin LM, Edwards MA, Li J, Yip CM, Deber CM (2012) Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide-membrane interactions. J Biol Chem 287(10):7738–7745
Yu H, Lu Y, Qiao X, Wei L, Fu T, Cai S, Wang Y (2015) Novel cathelicidins from pigeon highlights evolutionary convergence in avain cathelicidins and functions in modulation of innate immunity. Sci Rep. https://doi.org/10.1038/srep11082
Yu Q, Zhang Z, Sun J, Xia Y, Du Q, Liang D (2017) Effects of chain length and hydrophobicity/charge ratio of AMP on its antimicrobial activity. Sci China Chem 60(3):385–395
Zhao CX, Dwyer MD, Yu AL, Wu Y, Fang S, Middelberg AP (2015) A simple and low-cost platform technology for producing pexiganan antimicrobial peptide in E. coli. Biotechnol Bioeng 112(5):957–964
Zhao Y, Zhang M, Qiu S, Wang J, Peng J, Zhao P, Yan W (2016) Antimicrobial activity and stability of the d-amino acid substituted derivatives of antimicrobial peptide polybia-MPI. AMB Express 6(1):122
Zhong J, Wang W, Yang X, Yan X, Liu R (2013) A novel cysteine-rich antimicrobial peptide from the mucus of the snail of Achatina fulica. Peptides 39:1–5
Acknowledgements
The authors wish to thank SERB and UGC, Government of India, for financial support through major project. A special thanks to Prof. Dr. K. Ruckmani, Head and Director, Department of Pharmaceutical Technology, Centre for. Excellence in Nanobio Translational REsearch. (CENTRE), University College of Engineering, Bharathidasan Institute of Technology Campus, Anna University, Tiruchirappalli-620024, Tamil Nadu, India for her constant support.
Funding
This study was supported by Science and Engineering research board, Department of Science and Technology under the scheme of Empowerment and Equity Opportunities for Excellence in Science. Sanction Order No: SB/EMEQ-034/2014 dated 06.07.2015. University Grants Commission, National Fellowship for SC, Award Letter No.: F1-17.1/2017-18/RGNF-2017-18-SC-TAM-45554. Dated: 16/08/2017.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors declare no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Nagarajan, K., Marimuthu, S.K., Palanisamy, S. et al. Peptide Therapeutics Versus Superbugs: Highlight on Current Research and Advancements. Int J Pept Res Ther 24, 19–33 (2018). https://doi.org/10.1007/s10989-017-9650-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10989-017-9650-0